MicroRNA‑103 Regulates Tumorigenesis in Colorectal Cancer by Targeting ZO‑1

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2017 Nov 9

PMID 29115525

Citations 9

Authors

Jin Ke

Weiwei Shao

Yasu Jiang

Junfei Xu

Feng Li

Jun Qin

Affiliations

Soon will be listed here.

Abstract

Given the emerging role of microRNAs (miRs) in cancer progression, the present study investigated the role and underlying mechanism of miR‑103 in colorectal cancer (CRC). Reverse transcription‑quantitative polymerase chain reaction was conducted to quantify the expression levels of miR‑103 in clinical specimens and cell lines. The role of miR‑103 in CRC was examined using MTT, colony formation and transwell assays. In addition, a luciferase reporter assay was used to confirm an associated between the 3' untranslated region of zonula occuldens‑1 (ZO‑1) and miR‑103. The results demonstrated that miR‑103 was upregulated in CRC. Overexpression of miR‑103 promoted CRC cell proliferation and migration in vitro, whereas downregulation of miR‑103 inhibited cell proliferation and migration. ZO‑1 was identified as a direct target of miR‑103, revealing its expression to be inversely correlated with miR‑103 expression in CRC samples. In conclusion, the present study revealed that miR‑103 has strong tumor‑promoting effects via of targeting ZO‑1 in CRC and has potential development of miRNA‑based targeted approaches for the treatment of CRC.

Citing Articles

Downregulation of γ-Catenin by miR-195-5p Inhibits Colon Cancer Progression, Regulating Desmosome Function.

Piccinno E, Scalavino V, Labarile N, Bianco G, Savino M, Armentano R Int J Mol Sci. 2024; 25(1).

PMID: 38203664 PMC: 10779266. DOI: 10.3390/ijms25010494.

miR-195-5p as Regulator of γ-Catenin and Desmosome Junctions in Colorectal Cancer.

Piccinno E, Scalavino V, Armentano R, Giannelli G, Serino G Int J Mol Sci. 2023; 24(23).

PMID: 38069408 PMC: 10707010. DOI: 10.3390/ijms242317084.

Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis.

Barnas E, Skret-Magierlo J, Paszek S, Kaznowska E, Potocka N, Skret A Genes (Basel). 2023; 14(3).

PMID: 36980984 PMC: 10048324. DOI: 10.3390/genes14030712.

Role of zonula occludens in gastrointestinal and liver cancers.

Ram A, Vairappan B World J Clin Cases. 2022; 10(12):3647-3661.

PMID: 35647143 PMC: 9100728. DOI: 10.12998/wjcc.v10.i12.3647.

Footprints of microRNAs in Cancer Biology.

Rajasegaran Y, Azlan A, Rosli A, Yik M, Kang Zi K, Mohd Yusoff N Biomedicines. 2021; 9(10).

PMID: 34680611 PMC: 8533183. DOI: 10.3390/biomedicines9101494.

References

Giri S, Poindexter K, Sundar S, Firestone G . Arecoline induced disruption of expression and localization of the tight junctional protein ZO-1 is dependent on the HER 2 expression in human endometrial Ishikawa cells. BMC Cell Biol. 2010; 11:53. PMC: 2910664. DOI: 10.1186/1471-2121-11-53. View

Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A . A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007; 129(7):1401-14. PMC: 2681231. DOI: 10.1016/j.cell.2007.04.040. View

Yu D, Zhou H, Xun Q, Xu X, Ling J, Hu Y . microRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3. Oncol Lett. 2012; 3(6):1221-1226. PMC: 3392565. DOI: 10.3892/ol.2012.638. View

Martin T, Watkins G, Mansel R, Jiang W . Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer. 2004; 40(18):2717-25. DOI: 10.1016/j.ejca.2004.08.008. View

Ellis K, Cameron V, Troughton R, Frampton C, Ellmers L, Richards A . Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients. Eur J Heart Fail. 2013; 15(10):1138-47. DOI: 10.1093/eurjhf/hft078. View

Lee Y, Dutta A . The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007; 21(9):1025-30. PMC: 1855228. DOI: 10.1101/gad.1540407. View

Ni S, Xu L, Huang J, Feng J, Zhu H, Wang G . Increased ZO-1 expression predicts valuable prognosis in non-small cell lung cancer. Int J Clin Exp Pathol. 2013; 6(12):2887-95. PMC: 3843269. View

Zhang Y, Qu X, Li C, Fan Y, Che X, Wang X . miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1. Tumour Biol. 2014; 36(4):2277-85. DOI: 10.1007/s13277-014-2835-7. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

10.

Annibali D, Gioia U, Savino M, Laneve P, Caffarelli E, Nasi S . A new module in neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9 and -103, target the differentiation inhibitor ID2. PLoS One. 2012; 7(7):e40269. PMC: 3405103. DOI: 10.1371/journal.pone.0040269. View

11.

Zhu H, Lu J, Wang X, Zhang H, Tang X, Zhu J . Upregulated ZO-1 correlates with favorable survival of gastrointestinal stromal tumor. Med Oncol. 2013; 30(3):631. DOI: 10.1007/s12032-013-0631-7. View

12.

Lu J, Getz G, Miska E, Alvarez-Saavedra E, Lamb J, Peck D . MicroRNA expression profiles classify human cancers. Nature. 2005; 435(7043):834-8. DOI: 10.1038/nature03702. View

13.

Zhao P, Dai M, Chen W, Li N . Cancer trends in China. Jpn J Clin Oncol. 2010; 40(4):281-5. DOI: 10.1093/jjco/hyp187. View

14.

Brewster B, Rossiello F, French J, Edwards S, Wong M, Wronski A . Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site. Hum Mutat. 2012; 33(12):1665-75. DOI: 10.1002/humu.22159. View

15.

Kawauchiya T, Takumi R, Kudo Y, Takamori A, Sasagawa T, Takahashi K . Correlation between the destruction of tight junction by patulin treatment and increase of phosphorylation of ZO-1 in Caco-2 human colon cancer cells. Toxicol Lett. 2011; 205(2):196-202. DOI: 10.1016/j.toxlet.2011.06.006. View

16.

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

17.

Mazzoccoli G, Panza A, Valvano M, Palumbo O, Carella M, Pazienza V . Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol Int. 2011; 28(10):841-51. DOI: 10.3109/07420528.2011.615182. View

18.

Hong Z, Feng Z, Sai Z, Tao S . PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro. BMB Rep. 2014; 47(9):500-5. PMC: 4206725. DOI: 10.5483/bmbrep.2014.47.9.212. View

19.

Weber D, Johnen G, Bryk O, Jockel K, Bruning T . Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma--a pilot study. PLoS One. 2012; 7(1):e30221. PMC: 3256226. DOI: 10.1371/journal.pone.0030221. View

20.

Van Itallie C, Balda M, Anderson J . Epidermal growth factor induces tyrosine phosphorylation and reorganization of the tight junction protein ZO-1 in A431 cells. J Cell Sci. 1995; 108 ( Pt 4):1735-42. DOI: 10.1242/jcs.108.4.1735. View